Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Interactions
  4. Cardiology
  5. Antihypertensives
  6. Beta-Blockers

Beta-Blockers

  • Bone & Joint (53)
  • Cardiology (193)
    • Antiarrhythmics (58)
    • Antihypertensives (68)
      • ACEIs (25)
      • Aldosterone Antagonists (10)
      • Alpha-Blockers (3)
      • ARBs (25)
      • Beta-Blockers (9)
      • Calcium Channel Blockers (24)
      • Diuretics (20)
    • Antiplatelets/Anticoagulants (97)
    • Dyslipidemia Drugs (41)
    • Other (16)
  • Dermatology (36)
  • Diabetes & Endocrinology (30)
  • Gastroenterology (47)
  • Hematology & Oncology (6)
  • Infectious Diseases (170)
  • Men's Health (5)
  • Natural Medicines / Supplements / Food Interactions (89)
  • Neurology (111)
  • Nutrition & Obesity (5)
  • Psychiatry (120)
  • Resources (34)
  • Respiratory & Allergy (17)
  • Transplant Meds (11)
  • Women's Health (36)
1 - 9 of 9 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Medications for Overactive Bladder November 2024
Algorithm: Drug-Induced QT Prolongation: A Stepwise Approach
August 2022
Patient Education: How to Use Eye Meds May 2018
Commentary: OATP Drug Interactions March 2014
PL Voices: How to Handle Drug Interactions with Grapefruit January 2013
Chart: Potential Drug Interactions with Grapefruit January 2013
PL Voices: Role of Myrbetriq (mirabegron) in Managing Overactive Bladder October 2012
Commentary: QT Prolongation, Torsades de Pointes, & Medication Safety September 2011
Commentary: Systemic Effects of Ophthalmic Beta-Blockers March 2010
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved